Agenda Topics- Biomarkers in Neurodegeneration (AD/PD)
- Biomarkers in Neurological Diseases
- Biomarkers in Neuropsychiatric Diseases
- Biomarkers: Technical Considerations and Applications in Drug Development
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Distinguished FacultyIan Pike, Chief Operating Officer, Proteome Sciences Plc Paul Edison, Clinical Senior Lecturer, Imperial College London Martin Turner, Consultant Neurologist, Oxford University Alan Palmer, CSO, MS Therapeutics Jill Richardson, Director, Neuroinflammation DPU, GlaxoSmithKline Claude Wischik, Executive Chairman & Co Founder, TauRx Therapeutics Ltd Kim Henriksen, Head, Nordic Bioscience A/S John Allinson, Head of Biomarker Strategy, LGC Limited Brit Mollenhauer, Head of Clinical Research, Paracelsus-Elena-Klinik Christian Foerch, Head of the Cerebrovascular Research Group at the Department of Neurology, Goeth University Sabine Bahn, Professor, University of Cambridge Rachael Scahill, Senior Research Associate, Microscience Ltd
|